Table 3

Ratio between the level of high-sensitive cardiac troponin T in four different models

Model 1Model 2Model 3: total effectsModel 4: direct effects
RatioGSEP valueRatioGSEP valueRatioGSEP valueRatioGSEP value
Diagnosis
AECOPD1.471.10<0.0011.401.10<0.0011.271.110.0231.081.120.513
Pneumonia1.591.11<0.0011.531.11<0.0011.281.140.0541.011.150.929
Other lung diseases1.401.190.0471.311.180.1071.061.240.7750.961.240.839
Non-respiratory infection2.231.320.0042.291.320.0032.451.360.0031.791.360.061
Circulatory diseases2.781.14<0.0012.711.13<0.0012.121.18<0.0011.981.18<0.001
Cancer1.401.270.1541.371.260.1770.891.420.7450.731.420.370
Digestive diseases1.211.280.4421.211.270.4381.451.270.1231.321.270.242
Symptom diagnoses1.131.170.4421.131.170.4351.221.220.3271.121.220.578
Other diagnoses1.591.160.0021.561.160.0031.401.410.3261.221.410.556
Follow-up time in years1.131.03<0.0011.121.03<0.0011.111.040.0041.121.040.004
Baseline covariates
Study group vs references
LTOT candidates1.311.260.246Omitted
Institutional0.961.190.836Omitted
Outpatients0.821.180.2320.811.110.039
Outpatient clinic0.531.210.001Omitted
Covariates. baseline
Sex: female versus male0.631.09<0.0011.001.090.978
Age in quartiles1.121.040.0021.021.040.521
Pack-years in quartiles0.981.040.5420.941.030.071
Hypertension: Y vs N1.241.080.0090.941.080.420
Coronary artery disease: Y vs N1.101.180.5761.191.290.491
Q-wave ECG: Y vs N1.041.160.7831.011.140.962
Continuous baseline covariates in quartile
Creatinine1.141.040.0021.021.040.522
Leucocytes1.071.040.0721.071.040.056
C reactive protein1.021.040.6151.041.030.199
FEV10.781.05<0.0010.991.040.729
Arterial O2-tension0.891.050.0180.941.040.114
High-sensitive cardiac troponin T1.931.04<0.0011.871.03<0.001
Biomarkers during follow-up in quartiles
Leucocytes1.091.040.015
C reactive protein1.081.040.038
Creatinine1.061.030.052
Arterial O2-tension1.011.030.823
Heart rate1.081.030.028
  • AECOPD, acute exacerbation of chronic obstructive pulmonary disease; FEV1, forced expiratory volume in 1 s; GSE, geometric SE; LTOT, long-term oxygen treatment.;